RYDAPT

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: a6d395dce50c0715
Drug Approval Canada Name: RYDAPT
Product Name: RYDAPT
Status: Marketed
Status Date: 2017-09-08
Original Market Date: 2017-09-08
Din: 02466236
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EX10 MIDOSTAURIN
Atc Name: l 01 ex 10
Aig Number: 0159270001
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

MIDOSTAURIN

25 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a6d395dce50c0715

Type

Standard